Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Neurochemistry|October 1, 1985
Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranesM G Gillan, L E Robson, A T McKnight, et al.
Neuropeptides|February 1, 1985
[3H]-Dynorphin A (1-8): degradation profile and binding characteristics in brain homogenatesM G Gillan, L E Robson, A T McKnight, et al.
Brain Research|January 1, 1987
Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brainP Petrillo, A Tavani, D Verotta, et al.
Life Sciences|January 1, 1983
[3H]-dynorphin A (1-9): binding characteristics and degradation profile in brain homogenatesL E Robson, M G Gillan, A T McKnight, et al.
Lancet (London, England)|January 4, 1992
Platelet-derived growth factor BB for the treatment of chronic pressure ulcersM C Robson, L G Phillips, A Thomason, et al.
British Journal of Pharmacology|July 1, 1985
Pre-incubation of guinea-pig myenteric plexus with beta-funaltrexamine: discrepancy between binding assays and bioassaysA D Corbett, H W Kostelitz, A T McKnight, et al.
European Journal of Pharmacology|July 18, 1989
Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brainP Petrillo, A La Regina, M Sbacchi, et al.
Journal of Receptor Research|January 1, 1984
Radioligands for probing opioid receptorsS J Paterson, A D Corbett, M G Gillan, et al.
British Journal of Pharmacology|September 1, 1984
Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptorA D Corbett, M G Gillan, H W Kosterlitz, et al.
Pageof 3